When patients were divided into ‘high’ and ‘low’ CD8 expression based on the top 20% value of CD8A, we observed that elevated CD8A expression was associated with better patient survival in the TCGA liver cancer database (Figure 8E). Here, CD8A is linked to liver cancer.